Literature DB >> 16338167

Epidemiology of human alveolar echinococcosis in China.

Philip S Craig1.   

Abstract

Globally human alveolar echinococcosis (AE) is a rare zoonotic helminthic disease confined to the Northern Hemisphere as sporadic infections in rural populations, principally in some areas of North America, west-central Europe, the Near East, Siberia, Central Asia, Japan and China. In China the first human cases were reported from western regions in the 1960s, but most hospital records remain fragmented and inadequate. From the mid-1990s mass screening surveys using portable ultrasound scanners recorded higher prevalences (up to 6% by county) than in any other areas of the world with some village rates as high as 15%. Risk factors identified for AE cases included ethnicity, sex, age and occupation. The role of the dog in transmission of Echinococcus multilocularis to humans now appears to be significant and may be one of the most important risk factor, in combination with landscape/land-use features conducive to maintaining wildlife host populations.

Entities:  

Mesh:

Year:  2005        PMID: 16338167     DOI: 10.1016/j.parint.2005.11.034

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  49 in total

1.  Frequency distribution of Echinococcus multilocularis and other helminths of foxes in Kyrgyzstan.

Authors:  I Ziadinov; P Deplazes; A Mathis; B Mutunova; K Abdykerimov; R Nurgaziev; P R Torgerson
Journal:  Vet Parasitol       Date:  2010-04-14       Impact factor: 2.738

2.  Proposal of a computed tomography classification for hepatic alveolar echinococcosis.

Authors:  Tilmann Graeter; Wolfgang Kratzer; Suemeyra Oeztuerk; Mark Martin Haenle; Richard Andrew Mason; Andreas Hillenbrand; Thomas Kull; Thomas F Barth; Peter Kern; Beate Gruener
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Immunoprotection of recombinant Eg.myophilin against Echinococcus granulosus infection in sheep.

Authors:  Mingxing Zhu; Fu Gao; Zihua Li; Xiuqing Wang; Hao Wang; Zhisheng Wang; Jiaqing Zhao; Wei Zhao
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

4.  Investigation of Echinococcus multilocularis in foxes and dogs in Pakistan by detection of copro-DNA.

Authors:  Aisha Khan; Gérald Umhang; Zaib Ullah; Franck Boué; Vanessa Bastid; Ikram Ullah; Sajid Mahmood; Muhammad Sohail Afzal; Haroon Ahmed
Journal:  Parasitol Res       Date:  2021-01-14       Impact factor: 2.289

5.  Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice.

Authors:  Mingxing Zhu; Xiuqing Wang; Hao Wang; Zhisheng Wang; Jiaqing Zhao; Yana Wang; Wei Zhao
Journal:  Exp Ther Med       Date:  2015-06-18       Impact factor: 2.447

6.  Alveolar echinococcosis in Germany, 1992-2016. An update based on the newly established national AE database.

Authors:  Julian Schmidberger; Wolfgang Kratzer; Klaus Stark; Beate Grüner
Journal:  Infection       Date:  2017-10-31       Impact factor: 3.553

Review 7.  The global burden of alveolar echinococcosis.

Authors:  Paul R Torgerson; Krista Keller; Mellissa Magnotta; Natalie Ragland
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

8.  Canine echinococcosis in Kyrgyzstan: using prevalence data adjusted for measurement error to develop transmission dynamics models.

Authors:  I Ziadinov; A Mathis; D Trachsel; A Rysmukhambetova; T A Abdyjaparov; O T Kuttubaev; P Deplazes; P R Torgerson
Journal:  Int J Parasitol       Date:  2008-02-20       Impact factor: 3.981

9.  Rudolf Virchow and the recognition of alveolar echinococcosis, 1850s.

Authors:  Dennis Tappe; Matthias Frosch
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Human alveolar echinococcosis after fox population increase, Switzerland.

Authors:  Alexander Schweiger; Rudolf W Ammann; Daniel Candinas; Pierre-Alain Clavien; Johannes Eckert; Bruno Gottstein; Nerman Halkic; Beat Muellhaupt; Bettina Mareike Prinz; Juerg Reichen; Philip E Tarr; Paul R Torgerson; Peter Deplazes
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.